This is not the most recent version of the article. View current version (7 SEP 2011)

Intervention Protocol

Transplacental versus direct fetal corticosteroid treatment for accelerating fetal lung maturation where there is a risk of preterm birth

  1. Debby P Utama*,
  2. Caroline A Crowther

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 16 FEB 2011

DOI: 10.1002/14651858.CD008981


How to Cite

Utama DP, Crowther CA. Transplacental versus direct fetal corticosteroid treatment for accelerating fetal lung maturation where there is a risk of preterm birth (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 2. Art. No.: CD008981. DOI: 10.1002/14651858.CD008981.

Author Information

  1. The University of Adelaide, ARCH: Australian Research Centre for Health of Women and Babies, Discipline of Obstetrics and Gynaecology, Adelaide, South Australia, Australia

*Debby P Utama, ARCH: Australian Research Centre for Health of Women and Babies, Discipline of Obstetrics and Gynaecology, The University of Adelaide, Women's and Children's Hospital, 72 King William Road, Adelaide, South Australia, 5006, Australia. debby.utama@student.adelaide.edu.au. debbypu@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 16 FEB 2011

SEARCH

This is not the most recent version of the article. View current version (07 SEP 2011)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess if different routes of corticosteroid administration (maternal versus direct fetal) have effects on maternal health, and the risk of stillbirth, neonatal, perinatal, infant and child mortality and morbidity.